-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, the State Administration for Market Regulation, on April 19, the International Organization for Standardization (ISO) issued the "In Vitro Diagnostic Testing System-Requirements for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by Nucleic Acid Amplification Method" and recommendations" (ISO/TS5798:2022) international standard
This is the first international standard issued by ISO specifically for the detection of the new coronavirus
On April 19, the International Organization for Standardization (ISO) issued the "In Vitro Diagnostic Testing System - Requirements and Recommendations for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by Nucleic Acid Amplification" (ISO/TS5798:2022 ) international standards
Combined with the characteristics and detection requirements of the new coronavirus, the standard puts forward technical requirements for the design, development, verification, confirmation and implementation of virus detection methods around the nucleic acid amplification method for virus diagnosis and screening
The standard stipulates the whole process steps of the virus detection analysis experiment, and defines the comprehensive evaluation indicators of virus detection such as accuracy, detection limit, inclusiveness, and specificity, and comprehensively builds a quality system for virus detection, which provides the quality control of virus detection.
